Status:
COMPLETED
Induction of Abortion in the Second Trimester
Lead Sponsor:
Ain Shams Maternity Hospital
Conditions:
Abortion, Second Trimester
Eligibility:
FEMALE
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
To compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.
Detailed Description
The study will be conducted on 40 women who will undergo induction of abortion between 13-24 weeks with positive fetal pulsation. They will be randomly assigned to receive either only misoprostol 400 ...
Eligibility Criteria
Inclusion
- Abortion between 13-24 weeks with positive fetal pulsation due to congenital fetal malformations, severe preeclampsia, and maternal life-threatening conditions.
- Women have up to two cesarean sections.
Exclusion
- Abortion between 13-24 weeks with no fetal pulsation
- Women who have had two or more caesarean sections.
- Multiple pregnancies
- Uterine anomalies, such as septate and didelphis uteri.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06207539
Start Date
December 1 2022
End Date
April 30 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt